Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6IGA

Crystal structure of argininosuccinate lyase from Mycobacterium tuberculosis

6IGA の概要
エントリーDOI10.2210/pdb6iga/pdb
分子名称Argininosuccinate lyase, SULFATE ION (2 entities in total)
機能のキーワードargininosuccinate lyase, fumarate, tetramer, lyase
由来する生物種Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
タンパク質・核酸の鎖数4
化学式量合計199408.69
構造登録者
Chen, X.B.,Liu, X. (登録日: 2018-09-25, 公開日: 2019-02-06, 最終更新日: 2023-11-22)
主引用文献Chen, X.B.,Chen, J.,Zhang, W.,Wang, H.,Liu, X.,Zhou, W.,Yang, H.,Rao, Z.
Crystal structure and biochemical study on argininosuccinate lyase from Mycobacterium tuberculosis.
Biochem. Biophys. Res. Commun., 510:116-121, 2019
Cited by
PubMed Abstract: Argininosuccinate lyase (ASL) participates in arginine synthesis through catalysing a reversible reaction in which argininosuccinate (AS) converts into arginine and fumarate. ASL from Mycobacterium tuberculosis is essential for its growth. In this work, the crystal structure of the apo form of MtbASL was determined and reveals a tetrameric structure that is essential for its activity since the active sites are formed by residues from three different monomers. Subsequently, we determined the crystal structure of MtbASL-sulfate complex, and the ligand mimics the negatively charged intermediate. The complex structure and mutagenesis studies indicate that residues S282 and H161 might act as a catalytic dyad. A major conformational change in the MtbASL-SO complex structure could be observed upon sulfate binding, and this movement facilitates the interaction between substrate and the residues involved in catalysis. A different conformational change in the C-terminal domain could be observed in the MtbASL-SO complex compared with that in other homologues. This difference may be responsible for the lower activity of MtbASL, which is related to the slow growth rate of M. tuberculosis. The C-terminal domain is a potential allosteric site upon inhibitor binding. The various conformational changes and the diversity of the sequence of the potential allosteric site across the homologues might provide clues for designing selective inhibitors against M. tuberculosis.
PubMed: 30665717
DOI: 10.1016/j.bbrc.2019.01.061
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.776 Å)
構造検証レポート
Validation report summary of 6iga
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon